What to Expect at India Pharma Expo 2026: India’s Top Pharma Industry Convergence

As India strengthens its position as a global pharmaceutical powerhouse, industry leaders from across the life sciences ecosystem are set to converge at India Pharma Expo 2026, one of the country’s largest B2B pharma platforms. Co-hosted alongside the NextGen Pharma Summit & Awards 2026, the three-day gathering will take place from April 23–25, 2026, at the HITEX Exhibition Centre.

Organised by Elets Technomedia, with knowledge partner eHealth Magazine, the event is expected to attract over 15,000 attendees, 500+ delegates, and 300+ exhibitors from more than 15 countries, representing the entire pharmaceutical value chain.

A Platform Reflecting India’s Expanding Global Role

With the theme “India's Pharma Power – Building Global Bridges in Life Sciences & Innovation,” the expo aims to highlight India’s growing contribution to global drug manufacturing, vaccine production, biotech research, and pharmaceutical exports.

India continues to play a pivotal role in supplying affordable medicines worldwide, while also advancing in areas such as biosimilars, digital health integration, and AI-led drug discovery. Against this backdrop, India Pharma Expo 2026 seeks to create a strategic dialogue between manufacturers, policymakers, regulators, innovators, investors, and technology providers.

“India Pharma Expo 2026 is designed not merely as an exhibition platform but as a strategic ecosystem that fosters collaboration, innovation, and global partnerships. As India expands its footprint in life sciences, platforms like this are critical for enabling cross-border engagement and technology exchange”
- Dr. Ravi Gupta, Founder & CEO, Elets Technomedia & Editor-in-Chief, eHealth Magazine. 

Innovation Across the Pharma Lifecycle

The expo floor will showcase developments spanning the entire pharmaceutical lifecycle,  from research and formulation to manufacturing, compliance, and distribution.

Key focus areas include

• Smart Manufacturing & Pharma 4.0

• Biopharma & Biosimilars

• Continuous and Contract Manufacturing

• AI and Digital Automation in Drug Development

• CDMOs, Clinical Research & Pharmacovigilance

• APIs, Formulations, and Lab Technologies

By bringing these segments together under one roof, the event aims to offer stakeholders a comprehensive view of emerging technologies and evolving regulatory landscapes shaping the industry’s future.

Confirmed Exhibitors Strengthen Industry Representation

Several prominent industry players have already confirmed their participation at the expo. Early confirmed exhibitors include Huber, Datwyler, World Pack Automation, Rapidon, Bharat Rubbers, Antlia Engineering Works, and Bajaj Formulations.

Their participation underscores the event’s strong industry traction across manufacturing technologies, packaging automation, engineering solutions, rubber components, and pharmaceutical formulations. Additional national and international exhibitors are expected to be announced in the coming months.

Structured Business & Networking Opportunities

Beyond exhibitions and conference sessions, the event will facilitate curated Buyer–Seller Meetings and structured networking formats. These sessions are designed to enable direct engagement between manufacturers, procurement heads, hospital groups, digital health companies, regulatory consultants, and global solution providers.

Such targeted interactions are expected to support partnership building, technology collaborations, and discussions on potential cross-border expansion.

Recognising Excellence: NextGen Pharma Awards 2026

A key highlight of the three-day programme will be the NextGen Pharma Awards 2026, recognising excellence across manufacturing, R&D, digital transformation, biotech innovation, regulatory leadership, and pharmaceutical entrepreneurship.

With 15 broad categories and multiple sub-categories, the awards aim to spotlight organisations and leaders driving measurable impact within India’s evolving pharma ecosystem.

Why Hyderabad?

The choice of Hyderabad as host city reinforces the event’s strategic positioning. Often referred to as the “Vaccine Capital of the World,” Hyderabad has emerged as one of India’s leading pharmaceutical and biotechnology clusters. Its established manufacturing base, strong R&D infrastructure, and expanding biotech corridor make it a natural hub for global industry engagement.

Organising Legacy

With over two decades of experience in convening policy and industry leaders across healthcare, governance, and financial services, Elets Technomedia continues to curate platforms that encourage sectoral dialogue and industry advancement.

Registrations Open

Registrations for delegates, exhibitors, and industry participants are now open. Additional details are available at www.indiapharmaexpo.com

India Pharma Expo 2026 aims to serve as a collaborative gateway for innovation, partnerships, and global engagement, reinforcing India’s role at the forefront of pharmaceutical growth.